furosemide has been researched along with Deafness in 41 studies
Furosemide: A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
furosemide : A chlorobenzoic acid that is 4-chlorobenzoic acid substituted by a (furan-2-ylmethyl)amino and a sulfamoyl group at position 2 and 5 respectively. It is a diuretic used in the treatment of congestive heart failure.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ototoxicity was produced by the combinations of a constant dose of AMI (500 mg/kg; i." | 5.91 | N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease. ( Szymański, M; Zadrożniak, M; Łuszczki, JJ, 2023) |
| "A patient with Hodgkin's disease and renal insufficiency became deaf while being treated with high dose oral furosemide." | 5.26 | Deafness associated with oral furosemide. ( de Quesada, AM; Pickering, MJ; Rifkin, SI; Shires, DL, 1978) |
| "Children with hearing loss had lower birth weight for gestational age, more severe neonatal illness, with increased exposure to inotrope, steroid, gentamicin, vancomycin and furosemide, and more frequent physiological risk, elevated bilirubin and creatinine levels and acidosis, but no index child was found to have the m." | 4.31 | Cumulative risk factors contributing to hearing loss in preterm infants. ( Bitner-Glindzicz, M; Chant, K; Marlow, N, 2023) |
| "Kanamycin (500 mg/kg) and furosemide (50 mg/kg) were given to the healthy adult guinea pigs intramuscularly and intravenously to establish the deafness model." | 3.79 | [Math1 gene therapy for kanamycin and furosemide-induced deaf guinea pigs]. ( Gao, J; Guo, WW; Han, DY; Li, Z; Sun, AL; Sun, DX; Sun, JH; Wei, XN; Yang, SM; Zhang, XF, 2013) |
| " The present work reports the consequences on high- vs low-level DPOAEs of three types of cochlear impairments involving OHCs: progressive OHC degeneration of genetic origin in CD1 mice, complete cochlear ischemia in gerbils, and furosemide injection vs ischemia-reperfusion in gerbils." | 3.72 | Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli. ( Avan, P; Bonfils, P; Gilain, L; Mom, T, 2003) |
| "Ototoxicity was produced by the combinations of a constant dose of AMI (500 mg/kg; i." | 1.91 | N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease. ( Szymański, M; Zadrożniak, M; Łuszczki, JJ, 2023) |
| " Therefore, a reproducible and safe model for hearing-impaired animals is essential." | 1.72 | The ototoxic effect of locally applied kanamycin and furosemide in guinea pigs. ( Bako, P; Gerlinger, I; Löwenheim, H; Müller, M; Wolpert, S, 2022) |
| "Thirty-five neonates with sensorineural hearing loss (SNHL), identified by brainstem auditory evoked response (BAER), and 70 matched controls with normal BAERs were studied." | 1.28 | Neonatal sensorineural hearing loss associated with furosemide: a case-control study. ( Brown, DR; Sabo, D; Watchko, JF, 1991) |
| "A patient with Hodgkin's disease and renal insufficiency became deaf while being treated with high dose oral furosemide." | 1.26 | Deafness associated with oral furosemide. ( de Quesada, AM; Pickering, MJ; Rifkin, SI; Shires, DL, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (41.46) | 18.7374 |
| 1990's | 3 (7.32) | 18.2507 |
| 2000's | 11 (26.83) | 29.6817 |
| 2010's | 5 (12.20) | 24.3611 |
| 2020's | 5 (12.20) | 2.80 |
| Authors | Studies |
|---|---|
| Bako, P | 1 |
| Gerlinger, I | 1 |
| Wolpert, S | 1 |
| Müller, M | 1 |
| Löwenheim, H | 1 |
| Chant, K | 1 |
| Bitner-Glindzicz, M | 1 |
| Marlow, N | 1 |
| Zadrożniak, M | 1 |
| Szymański, M | 1 |
| Łuszczki, JJ | 1 |
| Chen, J | 1 |
| Liu, Z | 1 |
| Yan, H | 1 |
| Xing, W | 1 |
| Mi, W | 1 |
| Wang, R | 1 |
| Li, W | 1 |
| Chen, F | 1 |
| Qiu, J | 1 |
| Zha, D | 1 |
| Ramekers, D | 3 |
| Klis, SFL | 1 |
| Versnel, H | 5 |
| Waaijer, L | 1 |
| Klis, SF | 5 |
| Van Deurzen, MH | 1 |
| Hendriksen, FG | 1 |
| Grolman, W | 3 |
| Mesbahzadeh, B | 1 |
| Ajalloueyan, M | 1 |
| Kaka, GR | 1 |
| Askari, A | 1 |
| Hasanalifard, M | 1 |
| Zhang, XF | 1 |
| Yang, SM | 1 |
| Han, DY | 1 |
| Guo, WW | 1 |
| Sun, JH | 1 |
| Gao, J | 1 |
| Sun, DX | 1 |
| Sun, AL | 1 |
| Li, Z | 1 |
| Wei, XN | 1 |
| Havenith, S | 1 |
| Song, BN | 1 |
| Li, YX | 1 |
| Han, DM | 1 |
| Agterberg, MJ | 3 |
| van Dijk, LM | 1 |
| de Groot, JC | 3 |
| Oesterle, EC | 1 |
| Campbell, S | 1 |
| van Loon, MC | 1 |
| Avan, P | 1 |
| Bonfils, P | 1 |
| Gilain, L | 1 |
| Mom, T | 1 |
| Rais-Bahrami, K | 1 |
| Majd, M | 1 |
| Veszelovszky, E | 1 |
| Short, BL | 1 |
| Wise, AK | 1 |
| Richardson, R | 1 |
| Hardman, J | 1 |
| Clark, G | 1 |
| O'leary, S | 1 |
| Smoorenburg, GF | 1 |
| Nourski, KV | 1 |
| Abbas, PJ | 1 |
| Miller, CA | 1 |
| Robinson, BK | 1 |
| Jeng, FC | 1 |
| Hurley, PA | 1 |
| Crook, JM | 1 |
| Shepherd, RK | 1 |
| Arnold, W | 1 |
| Nadol, JB | 1 |
| Weidauer, H | 1 |
| Aso, S | 1 |
| Watanabe, Y | 1 |
| Lima da Costa, D | 1 |
| Erre, JP | 1 |
| Charlet de Sauvage, R | 1 |
| Popelar, J | 1 |
| Aran, JM | 1 |
| Konrad-Martin, D | 1 |
| Norton , SJ | 1 |
| Mascher, KE | 1 |
| Tempel, BL | 1 |
| Cook, DJ | 1 |
| Tudball, CF | 1 |
| Iaroshevich, VI | 1 |
| Bourke, E | 1 |
| Laitakari, K | 1 |
| Rifkin, SI | 1 |
| de Quesada, AM | 1 |
| Pickering, MJ | 1 |
| Shires, DL | 1 |
| Brown, DR | 1 |
| Watchko, JF | 1 |
| Sabo, D | 1 |
| Lynn, AM | 1 |
| Redding, GJ | 1 |
| Morray, JP | 1 |
| Tyler, DC | 1 |
| Lloyd-Mostyn, RH | 1 |
| Lord, IJ | 1 |
| Siciński, A | 1 |
| Brown, CB | 1 |
| Ogg, CS | 1 |
| Cameron, JS | 1 |
| Bewick, M | 1 |
| Stenbaek, O | 1 |
| Venkateswaran, PS | 1 |
| Schwartz, GH | 1 |
| David, DS | 2 |
| Riggio, RR | 1 |
| Stenzel, KH | 1 |
| Rubin, AL | 1 |
| Vargish, T | 1 |
| Benjamin, R | 1 |
| Shenkman, L | 1 |
| Heidland, A | 2 |
| Wigand, ME | 2 |
| Hitzig, P | 1 |
| Klockhoff, I | 1 |
| Lindblom, U | 1 |
1 review available for furosemide and Deafness
| Article | Year |
|---|---|
[Advances in nephrology. Chronic renal failure].
Topics: Bone and Bones; Cataract; Deafness; Female; Furosemide; Gastrointestinal Diseases; Humans; Hypercalc | 1974 |
1 trial available for furosemide and Deafness
| Article | Year |
|---|---|
High dose frusemide in acute reversible intrinsic renal failure. A preliminary communication.
Topics: Acute Kidney Injury; Adult; Clinical Trials as Topic; Deafness; Furosemide; Gentamicins; Humans; Kan | 1974 |
39 other studies available for furosemide and Deafness
| Article | Year |
|---|---|
The ototoxic effect of locally applied kanamycin and furosemide in guinea pigs.
Topics: Animals; Cochlea; Deafness; Furosemide; Guinea Pigs; Hair Cells, Auditory; Kanamycin; Spiral Ganglio | 2022 |
Cumulative risk factors contributing to hearing loss in preterm infants.
Topics: Case-Control Studies; Child; Deafness; Furosemide; Gentamicins; Hearing Loss; Humans; Infant; Infant | 2023 |
N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
Topics: Acetylcysteine; Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Auditory Threshold; Deafn | 2023 |
miR-182 prevented ototoxic deafness induced by co-administration of kanamycin and furosemide in rats.
Topics: Animals; Anti-Bacterial Agents; Deafness; Drug Combinations; Female; Furosemide; Kanamycin; MicroRNA | 2020 |
Simultaneous rather than retrograde spiral ganglion cell degeneration following ototoxically induced hair cell loss in the guinea pig cochlea.
Topics: Animals; Auditory Threshold; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, Brain St | 2020 |
The peripheral processes of spiral ganglion cells after intracochlear application of brain-derived neurotrophic factor in deafened guinea pigs.
Topics: Animals; Brain-Derived Neurotrophic Factor; Deafness; Furosemide; Guinea Pigs; Hair Cells, Auditory; | 2013 |
A model portraying experimental loss of hair cell: the use of distortion product otoacoustic emission in the assessment of rat's ear.
Topics: Amikacin; Animals; Deafness; Disease Models, Animal; Furosemide; Hair Cells, Auditory; Male; Otoacou | 2013 |
[Math1 gene therapy for kanamycin and furosemide-induced deaf guinea pigs].
Topics: Adenoviridae; Animals; Basic Helix-Loop-Helix Transcription Factors; Cochlea; Deafness; Ear, Inner; | 2013 |
Local delivery of brain-derived neurotrophic factor on the perforated round window membrane in Guinea pigs: a possible clinical application.
Topics: Animals; Brain-Derived Neurotrophic Factor; Deafness; Disease Models, Animal; Drug Administration Ro | 2015 |
Delayed electrical stimulation and BDNF application following induced deafness in rats.
Topics: Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Survival; Cochlea; Combined Mod | 2009 |
Enhanced survival of spiral ganglion cells after cessation of treatment with brain-derived neurotrophic factor in deafened guinea pigs.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Survival; Cochlear Implants; Deafness; Electric Sti | 2009 |
Supporting cell characteristics in long-deafened aged mouse ears.
Topics: Aging; Animals; Biomarkers; Calcium-Binding Proteins; Cell Differentiation; Deafness; Diuretics; Fur | 2009 |
Spiral ganglion cell morphology in guinea pigs after deafening and neurotrophic treatment.
Topics: Animals; Auditory Threshold; Brain-Derived Neurotrophic Factor; Cell Shape; Cell Size; Cell Survival | 2013 |
Physiopathological significance of distortion-product otoacoustic emissions at 2f1-f2 produced by high- versus low-level stimuli.
Topics: Acoustic Stimulation; Animals; Auditory Threshold; Brain Stem; Cochlea; Deafness; Disease Models, An | 2003 |
Use of furosemide and hearing loss in neonatal intensive care survivors.
Topics: Auditory Threshold; Brain Stem; Deafness; District of Columbia; Diuretics; Female; Furosemide; Heari | 2004 |
Resprouting and survival of guinea pig cochlear neurons in response to the administration of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cell Count; Cell Survival; Cochlea; Cochlear Implantatio | 2005 |
Time course of cochlear electrophysiology and morphology after combined administration of kanamycin and furosemide.
Topics: Action Potentials; Animals; Anti-Bacterial Agents; Cell Survival; Cochlea; Deafness; Electrophysiolo | 2007 |
Acoustic-electric interactions in the guinea pig auditory nerve: simultaneous and forward masking of the electrically evoked compound action potential.
Topics: Acoustic Stimulation; Adaptation, Physiological; Animals; Auditory Perception; Cochlear Nerve; Deafn | 2007 |
Schwann cells revert to non-myelinating phenotypes in the deafened rat cochlea.
Topics: Animals; Animals, Newborn; Cochlea; Deafness; Disease Models, Animal; Evoked Potentials, Auditory, B | 2007 |
Temporal bone histopathology in human ototoxicity due to loop diuretics.
Topics: Cochlea; Deafness; Diuretics; Ethacrynic Acid; Furosemide; Humans; Male; Middle Aged; Temporal Bone | 1981 |
Electrocochleography in the diagnosis of delayed endolymphatic hydrops.
Topics: Action Potentials; Adolescent; Adult; Aged; Aged, 80 and over; Audiometry, Evoked Response; Child; D | 1994 |
Bioelectrical cochlear noise and its contralateral suppression: relation to background activity of the eighth nerve and effects of sedation and anesthesia.
Topics: Acoustic Stimulation; Aminoglycosides; Anesthesia; Animals; Anti-Bacterial Agents; Body Temperature; | 1997 |
Effects of PMCA2 mutation on DPOAE amplitudes and latencies in deafwaddler mice.
Topics: Animals; Calcium-Transporting ATPases; Cation Transport Proteins; Deafness; Furosemide; Hair Cells, | 2001 |
Potentiators and bolus intravenous furosemide.
Topics: Child; Deafness; Diuretics; Dose-Response Relationship, Drug; Furosemide; Humans; Infant, Newborn; R | 2001 |
[Ototoxicity of some drug agents].
Topics: Age Factors; Aminoglycosides; Bleomycin; Cochlea; Deafness; Dimethyl Sulfoxide; Dose-Response Relati | 1975 |
Letter: Frusemide, bumetanide, and ototoxicity.
Topics: Bumetanide; Deafness; Diuretics; Edema; Female; Furosemide; Humans; Hyperparathyroidism; Male; Middl | 1976 |
Vestibular disorders in medically managed chronic renal insufficiency.
Topics: Adolescent; Adult; Aged; Audiometry; Caloric Tests; Deafness; Ear; Electronystagmography; Female; Fu | 1977 |
Deafness associated with oral furosemide.
Topics: Aged; Audiometry; Deafness; Furosemide; Hodgkin Disease; Humans; Male; Nephrotic Syndrome; Prednison | 1978 |
Neonatal sensorineural hearing loss associated with furosemide: a case-control study.
Topics: Auditory Threshold; Brain Stem; Child, Preschool; Deafness; Evoked Potentials, Auditory, Brain Stem; | 1991 |
Isolated deafness following recovery from neurologic injury and adult respiratory distress syndrome. A sequela of intercurrent aminoglycoside and diuretic use.
Topics: Aminoglycosides; Anti-Bacterial Agents; Deafness; Diuresis; Furosemide; Hearing Tests; Humans; Infan | 1985 |
Ototoxicity of intravenous frusemide.
Topics: Aged; Audiometry; Deafness; Discrimination, Psychological; Furosemide; Hearing Disorders; Humans; In | 1971 |
[Furosemide-induced deafness in decreased kidney function].
Topics: Administration, Oral; Deafness; Furosemide; Humans; Infusions, Parenteral; Kidney Diseases | 1972 |
Transient deafness from high doses of frusemide.
Topics: Deafness; Female; Furosemide; Humans; Kidney Failure, Chronic; Middle Aged | 1971 |
Ototoxicity induced by furosemide.
Topics: Adult; Deafness; Ear Diseases; Female; Furosemide; Humans; Injections, Intravenous; Kidney Diseases; | 1970 |
Deafness from furosemide.
Topics: Adult; Deafness; Furosemide; Humans; Kidney Failure, Chronic; Male | 1970 |
Deafness from furosemide.
Topics: Deafness; Furosemide; Humans | 1970 |
Diuretics and ototoxicity.
Topics: Adult; Deafness; Diuretics; Ethacrynic Acid; Female; Furosemide; Humans | 1971 |
Ototoxic side-effects of high doses of frusemide in patients with uraemia.
Topics: Audiometry; Deafness; Furosemide; Humans; Organ of Corti; Time Factors; Uremia | 1971 |
Glycerol test in Ménière's disease.
Topics: Audiometry; Deafness; Diuretics; Ear, Inner; Furosemide; Glycerol; Humans; Labyrinthine Fluids; Male | 1966 |